AN2 Therapeutics, Inc. (ANTX): 4 filed Sep 2, 2026

Form type

4

Filing date

Sep 2, 2026

Accession number

0001193125-26-380595

Filer

AN2 Therapeutics, Inc. (CIK 1880438)